需要改变人工心脏开发的目标：从完全可植入的永久性心室辅助设备到可穿戴治疗性心室辅助设备。
The need to change our objective for artificial heart development: from totally implantable permanent ventricular assist devices to wearable therapeutic ventricular assist devices.
出版信息
Artif Organs. 2010 Dec;34(12):1069-76. doi: 10.1111/j.1525-1594.2010.01163.x.
Abstract
As a therapeutic VAD to be combined with drugs, apheresis, and cellular implants, it is advisable to develop a wearable VAD for less than 6 months of application. Such an example was shown by describing the therapeutic BCM Gyro centrifugal VAD.
摘要
作为一种与药物、血浆分离和细胞植入相结合的治疗性 VAD，建议开发一种可穿戴式 VAD，应用时间不超过 6 个月。通过描述治疗性 BCM Gyro 离心 VAD，展示了这样一个例子。
Zotero 插件